Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Making quality of life assessment a dashboard for patient management.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Tendas A, Niscola P, Scaramucci L, Giovannini M, Dentamaro T, Perrotti AP, de Fabritiis P.
PMID: 24993396
Support Care Cancer. 2014 Sep;22(9):2311-2. doi: 10.1007/s00520-014-2342-9. Epub 2014 Jul 04.

No abstract available.

Cite
Tendas A, Niscola P, Scaramucci L, et al. Making quality of life assessment a dashboard for patient management. Support Care Cancer. 2014;22(9):2311-2doi: 10.1007/s00520-014-2342-9.
Tendas, A., Niscola, P., Scaramucci, L., Giovannini, M., Dentamaro, T., Perrotti, A. P., & de Fabritiis, P. (2014). Making quality of life assessment a dashboard for patient management. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(9), 2311-2. https://doi.org/10.1007/s00520-014-2342-9
Tendas, Andrea, et al. "Making quality of life assessment a dashboard for patient management." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 22,9 (2014): 2311-2. doi: https://doi.org/10.1007/s00520-014-2342-9
Tendas A, Niscola P, Scaramucci L, Giovannini M, Dentamaro T, Perrotti AP, de Fabritiis P. Making quality of life assessment a dashboard for patient management. Support Care Cancer. 2014 Sep;22(9):2311-2. doi: 10.1007/s00520-014-2342-9. Epub 2014 Jul 04. PMID: 24993396.
Copy Download .nbib Format: NLM
Response to Andrea Tendas et al.'s making quality of life assessment a dashboard for patients management.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Denis F.
PMID: 24919642
Support Care Cancer. 2014 Sep;22(9):2313. doi: 10.1007/s00520-014-2310-4. Epub 2014 Jun 13.

No abstract available.

Cite
Denis F. Response to Andrea Tendas et al.'s making quality of life assessment a dashboard for patients management. Support Care Cancer. 2014;22(9):2313doi: 10.1007/s00520-014-2310-4.
Denis, F. (2014). Response to Andrea Tendas et al.'s making quality of life assessment a dashboard for patients management. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(9), 2313. https://doi.org/10.1007/s00520-014-2310-4
Denis, Fabrice. "Response to Andrea Tendas et al.'s making quality of life assessment a dashboard for patients management." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 22,9 (2014): 2313. doi: https://doi.org/10.1007/s00520-014-2310-4
Denis F. Response to Andrea Tendas et al.'s making quality of life assessment a dashboard for patients management. Support Care Cancer. 2014 Sep;22(9):2313. doi: 10.1007/s00520-014-2310-4. Epub 2014 Jun 13. PMID: 24919642.
Copy Download .nbib Format: NLM
Cancer recurrence-A complex issue.

European journal of cancer care

Weller D.
PMID: 30255660
Eur J Cancer Care (Engl). 2018 Sep;27(5):e12943. doi: 10.1111/ecc.12943.

No abstract available.

Cite
Weller D. Cancer recurrence-A complex issue. Eur J Cancer Care (Engl). 2018;27(5):e12943doi: 10.1111/ecc.12943.
Weller, D. (2018). Cancer recurrence-A complex issue. European journal of cancer care, 27(5), e12943. https://doi.org/10.1111/ecc.12943
Weller, David. "Cancer recurrence-A complex issue." European journal of cancer care vol. 27,5 (2018): e12943. doi: https://doi.org/10.1111/ecc.12943
Weller D. Cancer recurrence-A complex issue. Eur J Cancer Care (Engl). 2018 Sep;27(5):e12943. doi: 10.1111/ecc.12943. PMID: 30255660.
Copy Download .nbib Format: NLM
The 150 most important questions in cancer research and clinical oncology series: questions 40-49.

Chinese journal of cancer

[No authors listed]
PMID: 28701224
Chin J Cancer. 2017 Jul 13;36(1):55. doi: 10.1186/s40880-017-0222-7.

Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology, which sparkle diverse thoughts, interesting communications, and potential collaborations among researchers all over the world. In this...

Cite
The 150 most important questions in cancer research and clinical oncology series: questions 40-49. Chin J Cancer. 2017;36(1):55doi: 10.1186/s40880-017-0222-7.
(2017). The 150 most important questions in cancer research and clinical oncology series: questions 40-49. Chinese journal of cancer, 36(1), 55. https://doi.org/10.1186/s40880-017-0222-7
"The 150 most important questions in cancer research and clinical oncology series: questions 40-49." Chinese journal of cancer vol. 36,1 (2017): 55. doi: https://doi.org/10.1186/s40880-017-0222-7
The 150 most important questions in cancer research and clinical oncology series: questions 40-49. Chin J Cancer. 2017 Jul 13;36(1):55. doi: 10.1186/s40880-017-0222-7. PMID: 28701224; PMCID: PMC5508686.
Copy Download .nbib Format: NLM
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Menis J, Reck M.
PMID: 32093850
J Thorac Oncol. 2020 Mar;15(3):308-310. doi: 10.1016/j.jtho.2019.11.031.

No abstract available.

Cite
Menis J, Reck M. Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?. J Thorac Oncol. 2020;15(3):308-310doi: 10.1016/j.jtho.2019.11.031.
Menis, J., & Reck, M. (2020). Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 15(3), 308-310. https://doi.org/10.1016/j.jtho.2019.11.031
Menis, Jessica, and Reck, Martin. "Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 15,3 (2020): 308-310. doi: https://doi.org/10.1016/j.jtho.2019.11.031
Menis J, Reck M. Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?. J Thorac Oncol. 2020 Mar;15(3):308-310. doi: 10.1016/j.jtho.2019.11.031. PMID: 32093850.
Copy Download .nbib Format: NLM
The fear of cancer recurrence literature continues to move forward: a review article.

Current opinion in supportive and palliative care

Maheu C, Galica J.
PMID: 29251693
Curr Opin Support Palliat Care. 2018 Mar;12(1):40-45. doi: 10.1097/SPC.0000000000000323.

PURPOSE OF REVIEW: The volume of literature addressing fear of cancer recurrence (FCR) is rapidly increasing. A summary of key developments in the research and treatment of FCR was published by Sharpe et al. in 2017, and the current...

Cite
Maheu C, Galica J. The fear of cancer recurrence literature continues to move forward: a review article. Curr Opin Support Palliat Care. 2018;12(1):40-45doi: 10.1097/SPC.0000000000000323.
Maheu, C., & Galica, J. (2018). The fear of cancer recurrence literature continues to move forward: a review article. Current opinion in supportive and palliative care, 12(1), 40-45. https://doi.org/10.1097/SPC.0000000000000323
Maheu, Christine, and Galica, Jacqueline. "The fear of cancer recurrence literature continues to move forward: a review article." Current opinion in supportive and palliative care vol. 12,1 (2018): 40-45. doi: https://doi.org/10.1097/SPC.0000000000000323
Maheu C, Galica J. The fear of cancer recurrence literature continues to move forward: a review article. Curr Opin Support Palliat Care. 2018 Mar;12(1):40-45. doi: 10.1097/SPC.0000000000000323. PMID: 29251693.
Copy Download .nbib Format: NLM
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer.

The oncologist

Langston AA, Quest TE, Abernethy ER, Campbell GP, Owonikoko TK, Pentz RD.
PMID: 32744382
Oncologist. 2020 Oct;25(10):e1586-e1588. doi: 10.1634/theoncologist.2020-0442. Epub 2020 Aug 27.

The oncology community is concerned that patients with cancer will be unfairly classified in pandemic allocation guidance. Past guidance either excluded patients with metastatic cancer from consideration or categorized them as having a survival of less than 1 year....

Cite
Langston AA, Quest TE, Abernethy ER, et al. Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. Oncologist. 2020;25(10):e1586-e1588doi: 10.1634/theoncologist.2020-0442.
Langston, A. A., Quest, T. E., Abernethy, E. R., Campbell, G. P., Owonikoko, T. K., & Pentz, R. D. (2020). Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. The oncologist, 25(10), e1586-e1588. https://doi.org/10.1634/theoncologist.2020-0442
Langston, Amelia A, et al. "Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer." The oncologist vol. 25,10 (2020): e1586-e1588. doi: https://doi.org/10.1634/theoncologist.2020-0442
Langston AA, Quest TE, Abernethy ER, Campbell GP, Owonikoko TK, Pentz RD. Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. Oncologist. 2020 Oct;25(10):e1586-e1588. doi: 10.1634/theoncologist.2020-0442. Epub 2020 Aug 27. PMID: 32744382; PMCID: PMC7436378.
Copy Download .nbib Format: NLM
[Colon cancer surgery in the high-risk patient].

Ugeskrift for laeger

Hartwig MFS, Gögenur I.
PMID: 32515325
Ugeskr Laeger. 2020 May 05;182(22).

The incidence of colon cancer increases with age. With national screening in Denmark, the incidence of early stage cancer is high. With the increasing possibilities of personalised treatment for colon cancer, it is important to choose the right treatment...

Cite
Hartwig MFS, Gögenur I. [Colon cancer surgery in the high-risk patient]. Ugeskr Laeger. 2020;182(22)
Hartwig, M. F. S., & Gögenur, I. (2020). [Colon cancer surgery in the high-risk patient]. Ugeskrift for laeger, 182(22), .
Hartwig, Morten F S, and Gögenur, Ismail. "[Colon cancer surgery in the high-risk patient]." Ugeskrift for laeger vol. 182,22 (2020).
Hartwig MFS, Gögenur I. [Colon cancer surgery in the high-risk patient]. Ugeskr Laeger. 2020 May 05;182(22). Danish. PMID: 32515325.
Copy Download .nbib Format: NLM
Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study.

Transplant international : official journal of the European Society for Organ Transplantation

Bunthof KLW, Steenbergen EJ, Hilbrands LB.
PMID: 32852855
Transpl Int. 2020 Dec;33(12):1693-1699. doi: 10.1111/tri.13724. Epub 2020 Oct 13.

The incidence and relevance of histological findings in removed allografts is unknown. In this study, we investigated the outcome of routine histopathological examination of removed allografts. We performed a retrospective cohort study in patients with kidney graft failure ≥3...

Cite
Bunthof KLW, Steenbergen EJ, Hilbrands LB. Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study. Transpl Int. 2020;33(12):1693-1699doi: 10.1111/tri.13724.
Bunthof, K. L. W., Steenbergen, E. J., & Hilbrands, L. B. (2020). Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study. Transplant international : official journal of the European Society for Organ Transplantation, 33(12), 1693-1699. https://doi.org/10.1111/tri.13724
Bunthof, Kim L W, et al. "Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study." Transplant international : official journal of the European Society for Organ Transplantation vol. 33,12 (2020): 1693-1699. doi: https://doi.org/10.1111/tri.13724
Bunthof KLW, Steenbergen EJ, Hilbrands LB. Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study. Transpl Int. 2020 Dec;33(12):1693-1699. doi: 10.1111/tri.13724. Epub 2020 Oct 13. PMID: 32852855; PMCID: PMC7756776.
Copy Download .nbib Format: NLM
Targeting fear of recurrence: the advantages of assessing psychosocial attributes and psychological dispositions.

The British journal of dermatology

Miniotti M, Ribero S, Leombruni P.
PMID: 32479645
Br J Dermatol. 2020 Oct;183(4):789-790. doi: 10.1111/bjd.19261. Epub 2020 Jul 21.

No abstract available.

Cite
Miniotti M, Ribero S, Leombruni P. Targeting fear of recurrence: the advantages of assessing psychosocial attributes and psychological dispositions. Br J Dermatol. 2020;183(4):789-790doi: 10.1111/bjd.19261.
Miniotti, M., Ribero, S., & Leombruni, P. (2020). Targeting fear of recurrence: the advantages of assessing psychosocial attributes and psychological dispositions. The British journal of dermatology, 183(4), 789-790. https://doi.org/10.1111/bjd.19261
Miniotti, M, et al. "Targeting fear of recurrence: the advantages of assessing psychosocial attributes and psychological dispositions." The British journal of dermatology vol. 183,4 (2020): 789-790. doi: https://doi.org/10.1111/bjd.19261
Miniotti M, Ribero S, Leombruni P. Targeting fear of recurrence: the advantages of assessing psychosocial attributes and psychological dispositions. Br J Dermatol. 2020 Oct;183(4):789-790. doi: 10.1111/bjd.19261. Epub 2020 Jul 21. PMID: 32479645.
Copy Download .nbib Format: NLM
Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study.

Annals of surgical oncology

Outani H, Kobayashi E, Wasa J, Saito M, Takenaka S, Hayakawa K, Endo M, Takeuchi A, Kobayashi H, Kito M, Morii T, Imanishi J, Ueda T.
PMID: 33146837
Ann Surg Oncol. 2021 Jul;28(7):3893-3901. doi: 10.1245/s10434-020-09306-8. Epub 2020 Nov 04.

BACKGROUND: Although the unpredictable malignant behavior of solitary fibrous tumors (SFTs) has been recognized, the clinical features and prognosis of metastatic SFTs have not been well documented due to the extreme rarity of these cases. The aim of this...

Cite
Outani H, Kobayashi E, Wasa J, et al. Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study. Ann Surg Oncol. 2020;28(7):3893-3901doi: 10.1245/s10434-020-09306-8.
Outani, H., Kobayashi, E., Wasa, J., Saito, M., Takenaka, S., Hayakawa, K., Endo, M., Takeuchi, A., Kobayashi, H., Kito, M., Morii, T., Imanishi, J., & Ueda, T. (2021). Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study. Annals of surgical oncology, 28(7), 3893-3901. https://doi.org/10.1245/s10434-020-09306-8
Outani, Hidetatsu, et al. "Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study." Annals of surgical oncology vol. 28,7 (2021): 3893-3901. doi: https://doi.org/10.1245/s10434-020-09306-8
Outani H, Kobayashi E, Wasa J, Saito M, Takenaka S, Hayakawa K, Endo M, Takeuchi A, Kobayashi H, Kito M, Morii T, Imanishi J, Ueda T. Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study. Ann Surg Oncol. 2021 Jul;28(7):3893-3901. doi: 10.1245/s10434-020-09306-8. Epub 2020 Nov 04. PMID: 33146837.
Copy Download .nbib Format: NLM
Surgery for pulmonary metastases.

The Surgical clinics of North America

Ramming KP.
PMID: 7423363
Surg Clin North Am. 1980 Aug;60(4):815-24. doi: 10.1016/s0039-6109(16)42184-5.

No abstract available.

Cite
Ramming KP. Surgery for pulmonary metastases. Surg Clin North Am. 1980;60(4):815-24doi: 10.1016/s0039-6109(16)42184-5.
Ramming, K. P. (1980). Surgery for pulmonary metastases. The Surgical clinics of North America, 60(4), 815-24. https://doi.org/10.1016/s0039-6109(16)42184-5
Ramming, K P. "Surgery for pulmonary metastases." The Surgical clinics of North America vol. 60,4 (1980): 815-24. doi: https://doi.org/10.1016/s0039-6109(16)42184-5
Ramming KP. Surgery for pulmonary metastases. Surg Clin North Am. 1980 Aug;60(4):815-24. doi: 10.1016/s0039-6109(16)42184-5. PMID: 7423363.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries